Year-over-year, this metric declined by 98.0%, from $248.00M to $5.00M. Over 4 years (FY 2021 to FY 2025), Share Buybacks shows a downward trend with a -37.0% CAGR.
High repurchases often signal management's confidence in the company's valuation or a strategy to improve earnings per share.
The cash outflow associated with the company buying back its own shares from the open market. This is a primary method f...
Common among mature, cash-generative companies; peers in the healthcare sector often balance this with R&D investment.
share_repurchases| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $934.00M | $935.00M | $930.00M | $600.00M | $854.00M | $830.00M | $826.00M | $163.00M | $140.00M | $200.00M | $119.00M | $0.00 | $0.00 | $0.00 | $0.00 | $248.00M | $208.00M | $78.00M | $0.00 | $5.00M |
| QoQ Change | — | +0.1% | -0.5% | -35.5% | +42.3% | -2.8% | -0.5% | -80.3% | -14.1% | +42.9% | -40.5% | -100.0% | — | — | — | — | -16.1% | -62.5% | -100.0% | — |
| YoY Change | — | — | — | — | -8.6% | -11.2% | -11.2% | -72.8% | -83.6% | -75.9% | -85.6% | -100.0% | -100.0% | -100.0% | -100.0% | — | — | — | — | -98.0% |